Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
SART1 is two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway.
Gene Name: | squamous cell carcinoma antigen recognized by T cells |
Synonyms: | SART1, Ara1, Allergen Hom s 1, HOMS1, HSnu66, IgE autoantigen, SART-1, Snu66, SNRNP110, SNU66 homolog, SART1(800) protein, SART1259, HSART-1, SART1(259) protein |
Target Sequences: | NM_005146 NP_005137.1 O43290 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.